ArticleInvestigative ophthalmology & visual science2025
FOXP4 Variants Are Associated With Plateau Iris and Angle Closure Glaucoma.
Article in Investigative ophthalmology & visual science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Purpose: Angle closure glaucoma (ACG) is a common cause of adult-onset vision loss that often presents with iris abnormalities and short axial lengths. Although it is heritable, little is known about the genetic risk factors underlying this condition. We thus conducted a disease gene discovery study in a family exhibiting an autosomal dominant triad of ACG, plateau iris, and short axial lengths. Methods: Pooled exome sequencing was performed to identify coding variants contributing to disease. The spatiotemporal expression pattern of candidate gene FOXP4 was evaluated via immunostaining in embryonic mouse eyes. YFP-tagged mutant and wild-type FOXP4 proteins were expressed in HEK-293T and ARPE-19 cells to evaluate nuclear localization, and an SRPX2-Luciferase reporter was used to ascertain variant effects on transcriptional regulation. We also reviewed more than 20,000 patients (primarily from the UK Biobank) diagnosed with glaucoma and/or disorders of the iris and ciliary body for additional FOXP4 variants and functionally validated them as described. Results: We identified a single likely pathogenic variant in transcription factor FOXP4: c.1433A>G (p.Q478R). FOXP4 is highly expressed in multiple structures relevant to the drainage angle, such as the periocular mesenchyme, iris, ciliary body, and cornea. The p.Q478R variant appears to be a hypomorphic allele that retains its transcriptional activity, but often mislocalizes to cytosolic aggregates. Comparable variants, including one found in another glaucoma patient, show similar mislocalization that may indicate protein instability. Conclusions: These data suggest that FOXP4 is important for anterior segment development and that variants therein are rare risk factors for ACG.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.